1. Home
  2. RGS vs ANVS Comparison

RGS vs ANVS Comparison

Compare RGS & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regis Corporation

RGS

Regis Corporation

HOLD

Current Price

$28.80

Market Cap

72.7M

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

N/A

Current Price

$1.38

Market Cap

76.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RGS
ANVS
Founded
1922
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.7M
76.6M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
RGS
ANVS
Price
$28.80
$1.38
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.50
AVG Volume (30 Days)
6.2K
529.8K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.39
EPS
2.41
N/A
Revenue
$224,485,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.86
N/A
Revenue Growth
6.83
N/A
52 Week Low
$19.31
$1.54
52 Week High
$31.50
$5.50

Technical Indicators

Market Signals
Indicator
RGS
ANVS
Relative Strength Index (RSI) 60.21 26.80
Support Level $26.09 N/A
Resistance Level $29.88 $2.02
Average True Range (ATR) 0.80 0.11
MACD 0.21 -0.03
Stochastic Oscillator 61.99 6.03

Price Performance

Historical Comparison
RGS
ANVS

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: